The Vet CENTERS for Mental Health Act of 2026 requires the Secretary of Veterans Affairs to ensure that every state meets a specific minimum number of mental health treatment centers within one year of enactment. For states in the contiguous United States, this minimum is calculated as the greater of one center per 30,000 square miles of land or one center per 55,000 veterans based on census data. Non-contiguous states and territories must maintain at least one center or match their existing count from January 1, 2020, whichever is higher. To achieve these targets, the Secretary may open new facilities using buildings provided by state, local, or tribal governments, and can establish outstations in place of full centers if multiple additional sites are needed in a single state.
This House resolution supports the goals of National Clinical Nurse Specialist Week, which is observed during the first week of September. It formally recognizes the contributions of these advanced practice nurses to patient care, quality improvement, and workforce development across various healthcare settings. The bill encourages the public to observe the week through appropriate programs and activities. Additionally, it reaffirms the House's commitment to ensuring that Clinical Nurse Specialists are accurately classified in federal labor statistics and supported in health workforce planning.
The 9-8-8 Implementation Act of 2026 expands federal funding and mandates insurance coverage for behavioral health crisis services, directly affecting individuals experiencing mental health or substance use emergencies as well as the providers who serve them. The bill authorizes grants to upgrade local lifeline call centers, build new crisis stabilization facilities, and train a larger workforce of behavioral health professionals. It requires Medicare, Medicaid, private group health plans, TRICARE, and other federal insurance programs to cover crisis response services with financial terms no more restrictive than standard medical care. Additionally, the legislation establishes a federal panel to develop training protocols for 9-1-1 dispatchers to better connect callers to appropriate crisis care rather than law enforcement responses.
The BEDROCK Act directs the Secretary of Commerce to designate a senior official who will lead federal efforts to boost the competitiveness and supply-chain resilience of the U.S. biomanufacturing industry. This official is tasked with identifying barriers to private sector investment, mapping complex regulatory pathways across agencies like the FDA and EPA, and publishing a prioritized action plan to address vulnerabilities in critical inputs such as enzymes and cell lines. The bill also requires the government to create a public web resource that consolidates federal information and designates specific agency points of contact to help businesses navigate commercialization processes. These requirements are set to terminate five years after the law is enacted, with periodic reports submitted to Congress to track progress.
The Advancing Botanical Drug Development Act of 2026 extends the market exclusivity period for new FDA-approved botanical drugs from five years to twelve years. This change directly affects pharmaceutical companies and other sponsors that develop plant-based medicines, providing them with a longer window of protection against generic competitors. The bill aims to offset the high costs and unique manufacturing challenges associated with developing these complex therapies by offering stronger financial incentives. By securing this extended exclusivity, the legislation seeks to encourage private investment in research for multi-target treatments of chronic and age-related diseases.
The Americans vs. Poisonous Pesticides Act amends federal pesticide laws to allow state courts to hear lawsuits alleging that pesticide labels fail to warn about health or environmental risks. It clarifies that a pesticide's federal registration and label approval do not automatically block these state claims, though they serve as initial evidence of compliance. The bill also permits companies to update their product labels to address new safety information without waiting for prior government approval, subject to potential review by the agency. These changes apply to both new lawsuits and cases already in progress, ensuring that federal rules do not limit existing state legal remedies for damages or injunctive relief.
The Public Transit Mental Health Awareness Act requires public transit agencies that receive federal assistance to display information about the national suicide prevention hotline in areas visible to passengers. This information must state that the service is free, confidential, and available around the clock. Agencies can meet this requirement by placing the notice on all their vehicles or in all their transit facilities, provided it does not block existing revenue-generating advertising space. The law includes a provision allowing agencies to remain compliant if they make reasonable efforts to restore displays that are damaged or removed, with the mandate taking effect one year after enactment.
This House resolution formally recognizes Overdose Awareness Day in the United States and calls for strengthened efforts to combat the opioid crisis. It directs the House of Representatives to pursue bipartisan legislation aimed at reducing the stigma associated with substance use disorders and drug overdoses. Additionally, the bill commits lawmakers to work with state and local governments, businesses, and health care providers to build a comprehensive system that supports prevention, treatment, harm reduction, and recovery for individuals affected by opioid use disorder.
The Part D Premium Protection Act of 2026 would establish a temporary premium credit for Medicare Part D prescription drug plan enrollees in 2027. This credit is designed to match the average premium reduction observed during the Part D Premium Stabilization Demonstration program between January 1, 2025, and the end of 2026. Under the bill's provisions, insurance sponsors would charge enrollees their standard premiums minus this specific credit amount, with the floor set at zero dollars. The Secretary of Health and Human Services would then reimburse the sponsors for the difference between the charged premium and the full applicable rate.
This House resolution expresses support for designating the week of August 25 through August 31, 2026, as "Black Breastfeeding Week" to raise awareness about racial disparities in maternal and infant health. The bill highlights data showing that Black mothers face higher barriers to breastfeeding and experience significantly higher infant mortality rates compared to White mothers. It calls on Congress to support policies that provide affordable healthcare, paid parental leave, and safe workplace accommodations for nursing mothers. Additionally, the resolution urges lawmakers to address broader systemic issues such as housing, transportation, and economic opportunity to improve health outcomes in Black communities.
